ALTERED ENFOTHELIAL FUNCTION AS A CARDIOVASCULAR RISK INDEX IN PATIENTS WITH METABOLIC SYNDROME

Authors
Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2007
INTERVENTION: Trade Name: BIOARGININA*OS 20FL 1,66G/20ML Product Name: LEVOARGININA Pharmaceutical Form: Oral solution CAS Number: 1119‐34‐2 Concentration unit: g gram(s) Concentration type: equal Concentration number: 1.66‐ CONDITION: METABOLIC SYNDROME ; MedDRA version: 9.1 Level: LLT Classification code 10048554 Term: Endothelial dysfunction PRIMARY OUTCOME: Main Objective: Primary end point(s): Secondary Objective: INCLUSION CRITERIA: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18‐64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range
Epistemonikos ID: 00c341f70c55dadcc96697a8a47367da75400333
First added on: Aug 21, 2024